Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PIK3CD | O00329 | 1/20 | 0.53 |
| ▸ | DPP4 | P27487 | 1/20 | 0.37 |
| ▸ | SLC6A2 | P23975 | 4/20 | 0.36 |
| ▸ | SLC6A4 | P31645 | 4/20 | 0.36 |
| ▸ | SLC6A3 | Q01959 | 3/20 | 0.36 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3483146 | 0.83 | PIK3CD (0.37) | PIK3CDDPP4SLC6A2SLC6A4SLC6A3 | |
| SCHEMBL17471254 | 0.82 | PIK3CD (0.49) | PIK3CDSLC6A2SLC6A4SLC6A3KCNH2 | |
| SCHEMBL10782 | 0.81 | PIK3CD (0.38) | PIK3CDDPP4SLC6A2SLC6A4SLC6A3 | |
| SCHEMBL30948781 | 0.81 | SLC6A2 (0.58) | SLC6A2SLC6A4SLC6A3KCNH2 | |
| SCHEMBL3483367 | 0.76 | DPP4 (0.37) | DPP4 | |
| SCHEMBL21789481 | 0.76 | DPP4 (0.41) | PIK3CDDPP4SLC6A2SLC6A4SLC6A3 | |
| SCHEMBL8030775 | 0.76 | PIK3CD (0.39) | PIK3CD | |
| SCHEMBL21938409 | 0.75 | SHBG (0.35) | PIK3CDDPP4SLC6A2SLC6A4SLC6A3 | |
| SCHEMBL3483290 | 0.75 | — | — | |
| SCHEMBL23872515 | 0.73 | DPP4 (0.40) | DPP4SLC6A2SLC6A4SLC6A3KCNH2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230071620-A1 | PHARMACEUTICAL COMPOUNDS FOR TREATMENT OF MEDICAL DISORDERS | ACHILLION PHARMACEUTICALS, INC. | 2023-03-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230071620-A1 | PHARMACEUTICAL COMPOUNDS FOR TREATMENT OF MEDICAL DISORDERS | CFD, TFPI, CFH | PIK3CD 131/4885DPP4 537/4885SLC6A2 755/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.